CANFIELD SCIENTIFIC, INC. v. MELANOSCAN, LLC - Before Newman, Dyk, and Reyna. Appeal from the Patent Trial and Appeal Board. Summary: The PTAB’s refusal to.
To embed, copy and paste the code into your website or blog:
The US Court of Appeals for the Federal Circuit overturned a finding of non-obviousness of certain claims relating to a device for the detection of skin cancer, finding that the Patent Trial & Appeal Board erred in applying the law of obviousness.
Canfield Scientific, Inc. v. Melanoscan, LLC, Case No. 19-1927 (Fed. Cir. Feb. 18, 2021) (Newman, J.)
Canfield Scientific filed a petition for
inter partes review challenging the validity of claims of a Melanoscan patent as obvious in view of several prior art references. After the Board upheld the validity of the challenged claims, Canfield appealed.
To embed, copy and paste the code into your website or blog:
A weekly summary of the precedential patent-related opinions issued by the Court of Appeals for the Federal Circuit and the opinions designated precedential or informative by the Patent Trial and Appeal Board.
John Bean Technologies Corp. v. Morris & Associates, Inc., Nos. 2020-1090, -1148 (Fed. Cir. (E.D. Ark.) Feb. 19, 2021). Opinion by Reyna, joined by Lourie and Wallach.
John Bean Technologies filed a patent infringement suit against its main competitor, Morris & Associates. The district court awarded Morris summary judgment that John Bean’s infringement claims were barred by equitable intervening rights.
Skin Cancer Detection Device is Combination of Familiar Elements natlawreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from natlawreview.com Daily Mail and Mail on Sunday newspapers.
The Federal Circuit had a slow week, issuing only 8 decisions (just 3 of them precedential). But among those was an interesting case with a question of first impression about the.